FDA Adverse Event
Injury
Summary report: N
ADVANTAGE TRANSVAGINAL MID-URETHRAL SLING SYSTEM
MDR report key: 8541164
·
Received April 22, 2019
Report
- Report Number
- MW5086067
- Event Type
- Injury
- Date Received
- April 22, 2019
- Date of Event
- August 13, 2014
- Manufacturer
- BOSTON SCIENTIFIC CORPORATION
- Product Code
- FTL
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Voluntary report
- Reporter Location
- AZ, US
- Reporter Occupation
- PATIENT
Narratives
Description of Event or Problem · 1
I WAS DIAGNOSED WITH CENTRAL SENSITIVITY SYNDROME, INCLUDING FIBROMYALGIA AND CHRONIC FATIGUE SYNDROME THAT I BELIEVE IS DIRECTLY RELATED TO THE DEVICE. THE DEVICE HAS PENETRATED THE VAGINAL WALL AD CAUSES PAIN AND BLEEDING. VAGINAL PROLAPSE IS NOW AT 50%. THERE IS ONLY ONE DR IN (B)(6) QUALIFIED TO REMOVE THE DEVICE IN ITS ENTIRETY AND HE IS LOCATED IN (B)(6). I AM CURRENTLY TRYING TO GET AN APPT. OTHER (B)(6) DRS ARE NOT COMFORTABLE REMOVING THE ENTIRE DEVICE, NOR ARE THEY QUALIFIED. MY HEALTH HAS BEEN FAILING SINCE THE DEVICE WAS PLACED DURING A HYSTERECTOMY ON (B)(6) 2007 AT (B)(6) CLINIC). FDA SAFETY REPORT ID# (B)(4).
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 331524 | ADVANTAGE TRANSVAGINAL MID-URETHRAL SLING SYSTEM | MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE | FTL | BOSTON SCIENTIFIC CORPORATION |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 46 YR | Required Intervention| S |